Long‐term relapse rates after cognitive behaviour therapy for anxiety and depressive disorders among older adults: A follow‐up study during COVID‐19
| Autor: | Piers Dawes, Cintia Botelha Dias, Viviana M. Wuthrich, Jessamine T. H. Chen, Joyce Siette, Heidi Hillebrandt, Olivia Maurice, Courtney Muir, Paul Strutt, Carly Johnco |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Coping (psychology) medicine.medical_specialty Coronavirus disease 2019 (COVID-19) frail older adults medicine.medical_treatment Anxiety behavioral disciplines and activities Quality of life COVID‐19 Recurrence medicine Humans Pandemics Depression (differential diagnoses) Aged Community and Home Care Geriatrics Depressive Disorder geriatrics treatment Cognitive Behavioral Therapy SARS-CoV-2 business.industry Brief Report Australia COVID-19 General Medicine Cognitive behaviour therapy Cognitive behavioral therapy Treatment Outcome depression Communicable Disease Control Quality of Life Brief Reports Female Geriatrics and Gerontology medicine.symptom business Follow-Up Studies Clinical psychology |
| Zdroj: | Australasian Journal on Ageing |
| ISSN: | 1741-6612 1440-6381 |
| DOI: | 10.1111/ajag.12928 |
| Popis: | Objective This study assessed the long‐term symptom relapse rates among older adults previously treated with cognitive behaviour therapy (CBT) for anxiety and/or depression during COVID‐19. Methods Participants were 37 older adults (M = 75 years, SD = 5; 65% female) previously treated with CBT for anxiety and/or unipolar depression who were re‐assessed an average of 5.6 years later, during the first Australian COVID‐19 lockdown. Results On average, there was no significant group‐level change in anxiety, depression or quality of life. When assessing change in symptoms based on clinical cut‐off points on self‐report measures, results suggest only 17%‐22% showed a relapse of symptoms by the COVID‐19 pandemic. Conclusions Findings suggest that CBT may be protective in coping with life stressors many years after treatment ends. However, results warrant replication to attribute continued symptom improvement to CBT given the lack of control group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text